Prestige Consumer Healthcare Inc. (PBH) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $49.05 (+0.53%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 30, 2026 | Keith Devas | Jefferies | $66.00 | +34.6% |
| Nov 5, 2024 | SUsan Anderson | Canaccord Genuity | $86.00 | +75.3% |
| Jun 21, 2024 | Linda Bolton Weiser | D.A. Davidson | $93.00 | +89.6% |
Top Analysts Covering PBH
PBH vs Sector & Market
| Metric | PBH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +66.5% | +153002.0% | +21.5% |
| P/E Ratio | 12.54 | 3.46 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $307M | $310M | $312M | 1 |
| 2027-03-31 | $315M | $319M | $320M | 1 |
| 2027-06-30 | $299M | $302M | $303M | 1 |
| 2027-09-30 | $326M | $329M | $331M | 1 |
| 2027-12-31 | $340M | $343M | $345M | 1 |
| 2028-03-31 | $350M | $353M | $355M | 1 |
| 2029-03-31 | $1.30B | $1.35B | $1.40B | 2 |
| 2030-03-31 | $1.35B | $1.37B | $1.42B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.20 | $1.22 | $1.23 | 1 |
| 2027-03-31 | $1.43 | $1.45 | $1.46 | 1 |
| 2027-06-30 | $1.02 | $1.04 | $1.05 | 1 |
| 2027-09-30 | $1.19 | $1.21 | $1.22 | 1 |
| 2027-12-31 | $1.26 | $1.27 | $1.28 | 1 |
| 2028-03-31 | $1.52 | $1.54 | $1.55 | 1 |
| 2029-03-31 | $5.32 | $5.42 | $5.68 | 1 |
| 2030-03-31 | $5.54 | $5.64 | $5.91 | 1 |
Frequently Asked Questions
What is the analyst consensus for PBH?
The consensus among 2 analysts covering Prestige Consumer Healthcare Inc. (PBH) is Buy with an average price target of $81.67.
What is the highest price target for PBH?
The highest price target for PBH is $93.00, set by Linda Bolton Weiser at D.A. Davidson on 2024-06-21.
What is the lowest price target for PBH?
The lowest price target for PBH is $66.00, set by Keith Devas at Jefferies on 2026-01-30.
How many analysts cover PBH?
2 analysts have issued ratings for Prestige Consumer Healthcare Inc. in the past 12 months.
Is PBH a buy or sell right now?
Based on 2 analyst ratings, PBH has a consensus rating of Buy (2.00/5) with a +66.5% upside to the consensus target of $81.67.
What are the earnings estimates for PBH?
Analysts estimate PBH will report EPS of $1.22 for the period ending 2026-12-31, with revenue estimated at $310M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.